Suchergebnisse - "Sönnerborg, Anders"

PubPharm (495)

51

Novel Naturally Occurring Dipeptides and Single-Stranded Oligonucleotide Act as Entry Inhibitors and Exhibit a Strong Synergistic Anti-HIV-1 Profile

enthalten in: Infectious diseases and therapy | 2022

von Ceña-Diez, R. | Singh, K. | Spetz, A. | +1

52

Integrase Strand Transfer Inhibitor Use and Cancer Incidence in a Large Cohort Setting

enthalten in: Open forum infectious diseases | 2022

von Greenberg, L. | Ryom, L. | Neesgaard, B. | +130

53

Pre-existing singleton E138A mutations in the reverse transcriptase gene do not affect the efficacy of first-line antiretroviral therapy regimens using rilpivirine in human immunodeficiency virus-infected patients

enthalten in: Clinical case reports | 2022

von Kuznetsova, A. | Lebedev, A. | Gromov, K. | +5

54

Incidence, Treatment, and Outcome of HIV-Associated Hematologic Malignancies in People Living with HIV in Sweden

enthalten in: AIDS research and human retroviruses | 2022

von Kieri, O. | Marrone, G. | Sönnerborg, A. | +1

55

Natural killer cells induce HIV-1 latency reversal after treatment with pan-caspase inhibitors

enthalten in: Frontiers in immunology | 2022

von Furtado Milão, J. | Love, L. | Gourgi, G. | +4

56

Peptide inhibitors for the inhibition of hiv capsid

enthalten in: Europäisches Patentamt | 2022

von NEOGI UJJWAL | SONNERBORG ANDERS | SINGH KAMLENDRA | +2

57

Peptide inhibitors for the inhibition of hiv capsid

enthalten in: Europäisches Patentamt | 2022

von NEOGI UJJWAL | SONNERBORG ANDERS | SINGH KAMLENDRA | +2

58

Integrative proteo-transcriptomic and immunophenotyping signatures of HIV-1 elite control phenotype : A cross-talk between glycolysis and HIF signaling

enthalten in: iScience | 2022

von Akusjärvi, S. | Ambikan, A. | Krishnan, S. | +9

59

Synthetic Mucin Gels with Self‐Healing Properties Augment Lubricity and Inhibit HIV‐1 and HSV‐2 Transmission

enthalten in: Advanced Science | 2022

von Kretschmer, M. | Ceña‐Diez, R. | Butnarasu, C. | +8

60

Pre‐existing singleton E138A mutations in the reverse transcriptase gene do not affect the efficacy of first‐line antiretroviral therapy regimens using rilpivirine in human immunodeficiency virus‐infected patients

enthalten in: Clinical Case Reports | 2022

von Kuznetsova, A. | Lebedev, A. | Gromov, K. | +5